Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Titel:
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Auteur:
van den Bent, Martin J Baumert, Brigitta Erridge, Sara C Vogelbaum, Michael A Nowak, Anna K Sanson, Marc Brandes, Alba Ariela Clement, Paul M Baurain, Jean Francais Mason, Warren P Wheeler, Helen Chinot, Olivier L Gill, Sanjeev Griffin, Matthew Brachman, David G Taal, Walter Rudà , Roberta Weller, Michael McBain, Catherine Reijneveld, Jaap Enting, Roelien H Weber, Damien C Lesimple, Thierry Clenton, Susan Gijtenbeek, Anja Pascoe, Sarah Herrlinger, Ulrich Hau, Peter Dhermain, Frederic van Heuvel, Irene Stupp, Roger Aldape, Ken Jenkins, Robert B Dubbink, Hendrikus Jan Dinjens, Winand N M Wesseling, Pieter Nuyens, Sarah Golfinopoulos, Vassilis Gorlia, Thierry Wick, Wolfgang Kros, Johan M